Brown: Risk Weighti...
Health Care: Drugs
Arrowhead Research Corporation (ARWR: NASDAQ)
$2.31 0.12 | 5.48%
05/17/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with ARWR
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Usertest1123
- ContributorStocks Under-$10 Setting Up...
- UserKJP 2012 Carbon Flash Fund
- Contributor8 Penny Stocks Get Delistin...
- UserWilliam T Blanchard - Medical
- UserCaroline
- UserSimon $9000
- Usertreneehill's pennies
Latest ARWR Headlines from TheStreet
- 5 Health Care Stocks Under $10 to Watch 04.30.13 | 02:04 pm
- 5 Stocks Under $10 Set to Soar 02.28.13 | 01:02 pm
- 4 Biotech Stocks Under $10 Moving Higher 02.20.13 | 09:02 pm
- 5 Stocks Under $10 Set to Trade Higher in November 11.01.12 | 01:11 pm
- Arrowhead's Management Presents At 2012 Wedbush PacGrow Life Sciences Management Access Conference (Transcript) 08.14.12 | 09:08 pm
- Arrowhead Research Corporation's CEO Discusses F3Q12 Results - Earnings Call Transcript 08.13.12 | 08:08 pm
- Arrowhead Research's CEO Hosts Alvos Acquisition Conference Call (Transcript) 05.08.12 | 12:05 am
- 6 Stocks Hitting New 52-Week Highs 11.10.11 | 01:11 pm
- 8 Penny Stocks Get Delisting Warning 01.04.11 | 07:01 am
- Arrowhead Research CEO Discusses F4Q2010 Results  Earnings Call Transcript 12.22.10 | 09:12 pm
Press Releases for ARWR
- Arrowhead Induces 90% Reduction In Hepatitis B Antigens In Chimpanzee With Chronic Infection: Data Follow Previous Report Of Reduction In Viral DNA - Business Wire 03.25.13 | 07:03 am
- Arrowhead RNAi Candidate ARC-520 Induces Greater Than 90% Reduction In Circulating HBV DNA In Chimpanzee With Chronic Hepatitis B - Business Wire 03.14.13 | 07:03 am
- Arrowhead To Host Analyst Event In New York To Discuss RNAi-based Hepatitis B Candidate ARC-520 - Business Wire 03.07.13 | 07:03 am
- Arrowhead Receives Notice Of Patent Allowance For New Protease Sensitive Masking Chemistry For DPC SiRNA Delivery System - Business Wire 02.28.13 | 07:02 am
- Arrowhead Data Demonstrates RNAi Candidate ARC-520 Silences Hepatitis B Virus - Business Wire 02.26.13 | 09:02 am
- Arrowhead Reports Fiscal 2013 First Quarter Financial Results - Business Wire 02.13.13 | 04:02 pm
- Lifshitz Law Firm Announces Investigation Of Arrowhead Research Corp., MEI Pharma, Inc., Park City Group, Inc., And The Toro Company - PR Newswire 02.07.13 | 05:02 pm
- Arrowhead To Report Fiscal 2013 First Quarter Financial Results - Business Wire 02.06.13 | 07:02 am
- Arrowhead To Present At Upcoming Scientific Conferences - Business Wire 02.01.13 | 07:02 am
- Arrowhead Announces Pricing Of A Public Offering Of Common Stock And Warrants - Business Wire 01.25.13 | 09:01 am
Partner Headlines for ARWR
- Arrowhead Research Receives Notice of Patent Allowance for New Formulation of DPC siRNA Delivery System Showing 500-Fold Increase in Potency - Benzinga 10.16.12 | 09:10 am
- Arrowhead Sells 2.3M Shares, 1.7M Warrants for $6.2M - Benzinga 08.13.12 | 09:08 am
- Anti-Obesity Drug CAUSES Trouble for Arrowhead and 4 Stocks that Have Hit 52-Week Lows - Wall St. Cheat Sheet 06.27.12 | 10:06 am
- 4 Smaller Alternatives to Big Pharma Obesity Treatments - Benzinga 05.25.12 | 01:05 pm
- Tekmira: RNAi Company With Long Term Potential, Short Term Catalysts - Seeking Alpha 03.07.12 | 08:03 am
- Arrowhead Reports Q1 EPS of $(0.02) - Benzinga 02.10.11 | 04:02 pm
- UPDATE 1-Arrowhead co, Smith & Nephew to make cartilage product - Reuters 10.18.10 | 08:10 am
